221 results
Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.436 - Advancing Equity in Food Allergy Prevention – Insights and Takeaways from CFAAR’s Summit for Advancing Equity in Food Allergy

Thumbnail

D3.437 - An EAACI Task Force Initiative for Visualizing Historical Pollen and Spore Calendars in Europe

Thumbnail

D3.438 - Advances in Automated Pollen Monitoring in Mediterranean Regions: New Developments from the SYLVA Project in Córdoba (Spain)

Thumbnail

D3.439 - On-demand treatment of hereditary angioedema attacks: Assessing self-treatment, outcomes and barriers to early intervention

Thumbnail

D1.171 - Preventive Effects of Lactococcus lactis on Ovalbumin-Induced Food Allergy in Mice

Thumbnail

D1.175 - Impact of dog ownership on allergen exposure and tolerance development: Analysis of Can f 1 levels in house dust samples

Thumbnail

D1.285 - Analysis of systemic food reactions in patients sensitized to Bet v1 in Madrid (Spain)

Thumbnail

D1.315 - Classifying the unclassifiable: diagnosis, characterization, and management of adults with unclassified primary antibody deficiency (unPAD)

Thumbnail

D1.72 - Comparison of the allergenic composition of available SPTs for the diagnosis of sensitization to D. pteronyssinus

Thumbnail

D2.291 - The level of knowledge of adolescent and young adults about food allergies and anaphylaxis: Key information that can save lives - a pilot study

Thumbnail

D2.387 - Reducing the Carbon Footprint of Cetirizine Prescription: Exploring Patient Perspectives on Formulation Choice in an Allergy Clinic

Thumbnail

D2.396 - Evaluating Advanced Fabric Care Technologies for Effective Dust Mite Eradication to Mitigate the Risk of Asthma

Thumbnail

D2.422 - Supporting second victims: linkages between patient safety and well-being of healthcare workers in allergy departments

Thumbnail

D1.390 - Long-term safety and efficacy of navenibart in participants with hereditary angioedema (HAE): Initial combined results from ALPHA-STAR and ALPHA-SOLAR

Thumbnail

D1.397 - Eosinophilic Pneumonia Triggered by Toxocara canis in a Patient with Kartagener Syndrome: A Case Report Highlighting Diagnostic Challenges and Interdisciplinary Management

Thumbnail

D1.398 - Retrospective study of the effect of bacterial immunotheraphy on patients with chronic respiratory diseases

Thumbnail

D1.404 - Use of inactivated polybacterial mucosal vaccine (IPMV) as part of the treatment for the reduction of recurrent acute respiratory infections

Thumbnail

D1.414 - Parents’ hesitancy towards vaccination: a Cross-sectional study in Saudi Arabia